The estimated Net Worth of Timothy Ludlow is at least $3.7 Million dollars as of 18 June 2021. Mr. Ludlow owns over 28,714 units of Covetrus stock worth over $1,523,958 and over the last 5 years he sold CVET stock worth over $2,171,638. In addition, he makes $0 as Executive Vice President and Chief Transformation Officer at Covetrus.
Timothy has made over 8 trades of the Covetrus stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 28,714 units of CVET stock worth $751,158 on 18 June 2021.
The largest trade he's ever made was exercising 72,604 units of Covetrus stock on 21 July 2020 worth over $26,863. On average, Timothy trades about 16,230 units every 43 days since 2020. As of 18 June 2021 he still owns at least 72,604 units of Covetrus stock.
You can see the complete history of Mr. Ludlow stock trades at the bottom of the page.
Timothy Ludlow serves as Executive Vice President, Chief Transformation Officer of the Company. Mr. Ludlow was having served as our Senior Vice President and Chief Transformation Officer since February 2019. Prior to such appointment, Mr. Ludlow served from August 2018 as Chief Integration and Transformation Officer and, from March 2015 to August 2018, as Chief Financial Officer of Vets First Choice. From October 2012 to March 2015, Mr. Ludlow served as Chief Financial Officer of Pine State Trading Company, a beverage distribution company, and from April 2008 until September 2012, Mr. Ludlow served as Senior Vice President and Treasurer of C&S Wholesale Grocers. Mr. Ludlow is a qualified UK accountant, FCCA.
Timothy Ludlow is 54, he's been the Executive Vice President and Chief Transformation Officer of Covetrus since 2020. There are 13 older and 13 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.
Timothy's mailing address filed with the SEC is 7, Custom House Street, India Street, Portland, Cumberland County, Maine, 04101, United States.
Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin, and Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Covetrus executives and other stock owners filed with the SEC include: